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Background: In England, coverage for childhood vaccines have decreased since 2012/13 in the context of
an increasingly visible anti-vaccination discourse. We determined whether anti-vaccination sentiment is
the likely cause of this decline in coverage.
Methods: Descriptive study triangulating a range of data sources (vaccine coverage, cross-sectional sur-
vey of attitudes towards vaccination, UK-specific Twitter social media) and assessing them against the
following Bradford Hill criteria: strength of association, consistency, specificity, temporality, biological
gradient and coherence.
Results: Strength of association: compared with well-documented vaccine scares, the decline in child-
hood vaccination seen since 2012/13 is 4–20 times smaller; consistency: while coverage for completed
courses of the hexavalent and meningococcal vaccines decreased by 0.5–1.2 percentage points (pp)
between 2017 and 2019, coverage for the first dose of these vaccines increased 0.5–0.7 pp; specificity:
Since 2012–13, coverage decreased for some vaccines (hexavalent, MMR, HPV, shingles) and increased
for others (MenACWY, Td/IPV, antenatal pertussis, influenza in 2 years of children), with no age-
specific patterns. Temporality and biological gradient: the decline in vaccine coverage was preceded by
an increase in vaccine confidence and a decrease in the proportion of parents encountering anti-
vaccination materials.
Coherence: attitudes towards vaccination expressed on Twitter in the UK became increasingly positive
between 2017 and 2019 as vaccine coverage for childhood vaccines decreased.
Conclusions: In England, trends in vaccine coverage between 2012/13 and 2018/19 were not homogenous
and varied in magnitude and direction according to vaccine, dose and region. In addition, confidence in
vaccines increased during the same period. These findings are not compatible with anti-vaccination sen-
timent causing a decline in vaccine coverage In England.
 2020 The Authors. Published by Elsevier Ltd. This is an open access articleunder the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
England offers a free, comprehensive, national immunisation
programme throughout the life course and is regarded as an inno-
vative and successful programme worldwide. It was the first coun-
try to implement a routine national programme for group C
meningococcal (MenC) vaccine in 1999, a national antenatal per-
tussis immunisation programme in 2012 which rapidly achieved
high vaccine uptake, and 4CMenB, a protein-based meningococcal
group B (MenB) vaccine into the national infant immunisationprogramme in 2015 [1]. Vaccine coverage for most routine child-
hood programmes in England has been over 90% since the early
1990s [2]. Coverage for the measles, mumps and rubella (MMR)
vaccine peaked 92.7% at 2013/14 following a decreasing to around
80% in the early 2000s as a result of a discredited alleged associa-
tion between the vaccine and autism [3]. Coverage for the com-
pleted course of primary combined diphtheria, tetanus, pertussis,
polio and Haemophilus Influenzae type b vaccine (DTaP/IPV/Hib)
at two years, which had not been affected by the MMR concerns,
peaked at 96.3% in 2012/13 [2]. Since then, coverage for childhood
vaccines has been declining slowly but steadily. By 2018/19, cover-
age had declined for all childhood routine vaccinations in children
under the age of 5 years, with DTaP/IPV/Hib coverage at 12 months
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coverage measured at 24 months declining by 2.3 pp since
2013/14 [2].
Globally, since 2012/13, interest in vaccination and vaccine
safety has increased [4] and confidence in vaccines, measured
through perceived vaccine safety and effectiveness [5] has become
increasingly reported in the media. Anti-vaccination is not new [6],
and the modern vaccination era (since the 1970s) has seen several
scares linked to specific vaccines. Examples include alleged links
between pertussis vaccine and encephalopathy along with MMR
and autism in the UK [3,7], Polio and infertility in Nigeria [8] and
human papillomavirus (HPV) vaccine and complex regional pain
syndrome in Japan [9]. Each of these was country-specific and
vaccine-specific. In the current digital era, there are legitimate con-
cerns that anti-vaccination sentiment is spreading online and will
affect more vaccines in more countries [6].
The perceived prominence of the anti-vaccination movement
has prompted increasing focus on vaccine hesitancy and resulted
in a number of high-level reports, including those by the World
Health Organization [10] and the European Commission [5]. These
reports, however, still show a mixed, country specific picture. The
European Commission report on the state of vaccine confidence
showed that, between 2015 and 2018, overall confidence in vacci-
nes had decreased in Poland and the Czech Republic, but had
increased in Greece, Italy and the UK [5]. Yet, in the UK, the recent
decrease in coverage for some vaccines has been interpreted as a
programme-wide decline and largely attributed to increasing
anti-vaccination sentiment [11,12,13]. This perceived association
has also become part of the prevalent discourse among public
health professionals [14]. The aim of this study is to challenge this
perception. In order to determine whether anti-vaccination is the
likely cause of the decline in vaccine coverage in England, we
examined and triangulated various vaccination-related data
against the relevant Bradford Hill Criteria [15], namely strength
of association, consistency, specificity, temporality, biological gra-
dient and coherence.2. Methods
We used vaccine coverage data from The Coverage of Vaccina-
tion Evaluated Rapidly (COVER) and ImmForm, the two routine
vaccine coverage surveillance systems used by Public Health Eng-
land (PHE) [16,17]. These systems measure vaccine coverage at
6 months, 12 months, 2 years and 5 years of age and the data is
publicly available online through a series of reports. Vaccine cover-
age data for years that precede the introduction of the COVER
surveillance systems were retrieved from the publicly available
Health Protection Agency archive. Coverage for vaccines delivered
in the first year of life but measured later (at 2 or 5 years) reflect
past performance. We also used data on attitudes to vaccine col-
lected as part of the PHE longitudinal attitudinal survey [18], and
UK-specific vaccine related tweets posted on Twitter, extracted
and analysed using the Crowdbreaks platform. In brief, Crowd-
breaks generates country-specific trends of vaccine sentiment in
real-time. The platform collects tweets containing certain key-
words and uses Natural Language Processing to predict a label of
1 (anti-vaccine), 0 (neutral) or +1 (pro-vaccine) based solely on
the text field. The vaccine sentiment index s is calculated as the
mean of all labels predicted within a certain time window [19].
Furthermore, tweets were only included if they contained geo
coordinates, a place, or a user location which could be mapped to
the UK. For this process, the Geonames database (geonames.org)
was used. To make the data used in this paper easily accessible,
we have listed all the data sources and where to access them in
Appendix 1. For each of the Bradford Hill Criteria employed, weidentified whether the data collected fulfilled the criteria
employed.
2.1. Criterion 1: Strength of association
This criterion explains that the larger an association between
exposure and disease, the more likely it is to be causal. In order
to test this, we compared the magnitude of the decrease in vaccine
coverage for DTaP/IPV/Hib and MMR1 measured at 2 years of age
in England since 2012/13 with the decreases that occurred during
well-documented vaccine scares, namely the MMR and pertussis
vaccines in England in the 1990s/2000 s and 1970s respectively.
2.2. Criterion 2: Consistency
The consistency criterion is upheld when multiple epidemiolog-
ical studies using a variety of locations, populations, and methods
show a consistent association between two variables with respect
to the null hypothesis [15]. If a generic anti-vaccination sentiment
was the main cause of the decrease in vaccine coverage, it should
impact all regions equally and all doses of vaccines: for example,
a scare about the DTaP/IPV/Hib vaccine should cause a decrease
in coverage for the first dose as well as the third dose. To test this
criterion, we described vaccine coverage across different regions of
England and for different doses of the same vaccine.
2.3. Criterion 3: Specificity
This criterion suggests that associations are more likely to be
causal when the exposure causes only one specific disease. While
this criterion is considered to be one of the weakest from an epi-
demiological perspective [15], in this context it generates an inter-
esting hypothesis: either a specific scare leads to a decline in
coverage of a specific vaccine, or a generic change in sentiment
towards vaccination causes a decline in coverage of all vaccines.
Another, less likely, but nevertheless plausible hypothesis would
be that the scare only affects a specific age group (young children,
for example). There is no simple way to explain how attitudes
towards vaccination would lead to a decrease in coverage for some,
but not all, vaccines across different age groups. In order to test
this, we conducted and compared three analyses: (i) coverage for
the measles- and DTP-containing vaccines at 2 years of age in Eng-
land over the MMR scare period (late 1990s/early 2000s); (ii) cov-
erage for the polio- and pertussis-containing vaccines at 2 years of
age in England over the pertussis scare period (1970s); and (iii)
coverage for DTaP/IPV/Hib (at 12 months), HPV (in school year
9), MenACWY (in school year 10), MMR1 (at 2 years), MMR2 (at
5 years) seasonal influenza (at 2 years), Td/IPV booster (in school
year 10), antenatal pertussis (targeting pregnant women) and shin-
gles (among 70 year-olds) vaccines over the period of reported
increasing anti-vaccination sentiment between 2012/13 and
2017/18, the most recent year with data available for all vaccines.
2.4. Criteria 4 and 5: Biological gradient and temporality
These two criteria suggest that for an association to be causa-
tive, the exposure has to precede the outcome, and that the magni-
tude of the outcome increases with the magnitude of the exposure,
(acknowledging that the relationship does may not be linear). In
order to test these criteria, we described trends in the proportion
of parents who automatically vaccinated their 2 year-old children
when their vaccines were due, obtained from an ongoing national
longitudinal survey of attitudes to vaccines [18], and compared
them with trends in DTaP/IPV/Hib coverage among children in this
age group.
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Coherence suggests that the cause and effect mechanism should
make sense with all knowledge available to the researcher. In other
words, coherence should be used to demonstrate a comprehensible
story regarding the causal pathway between exposure and out-
come [15]. When this concept is applied to the causes of decreasing
vaccination coverage, anti-vaccination sentiment should be
increasing as vaccine coverage decreases in order to generate a
coherent causal pathway. In order to measure attitudes towards
vaccination in generic terms, we measured the trends in vaccine
sentiment as expressed by activity on Twitter about vaccination0
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Fig 1. Vaccine coverage for selected vaccines duringin the UK between 2017 and 2019, using the Crowdbreaks platform
[19].
This study was based on secondary use of previously collected
aggregated data and did not require ethics approval.
3. Results
3.1. Strength of association
Vaccine scares have historically led to rapid, large declines in
vaccine coverage. Between 1997/98 and 2003/04, coverage
for MMR1 at 2 years dropped 11 pp to 80% (Fig. 1a). Similarly, at 2 years, England, 1988-2013
5 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985
sis vaccine, England, 1966-1985
2015/16 2016/17 2017/18 2018/19
s containing vaccines, England, 2011-2019
MMR 1 at 2 years
periods of change towards vaccine sentiment.
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1971 and 1976 (Fig. 1b). By contrast, in England, coverage for all
primary immunisations measured at 1 or 2 years of age have con-
sistently remained over 90% since 2012/13, with the exception of
rotavirus (89.7% in 2018/19), which traditionally achieves lower
coverage because of the strict criteria for timing of both the first
and second dose of vaccine and because catch up is not recom-
mended after the age of 6 months of age. Between 2012/13 and
2018/19, coverage for DTaP/IPV/Hib measured at 12 months and
for MMR measured at 24 months lost 2.6 and 2.3 pp, respectively
(Fig. 1c).
3.2. Consistency
Between 2012/13 and 2018/19, vaccine coverage decreased in
all English regions for both MMR1 and DTaP/IPV/Hib measured at
2 years of age. However, compared with London, the decline was
almost 3 times smaller for DTaP/IPV/Hib in the North East, and
more than 10 times smaller for MMR1 in the South East (Table 1).
Between July 2017 and April 2019, while coverage for the com-
pleted primary course of the MenB vaccine (2 doses, measured at
12 months) decreased by 0.5 pp to 92.2%, 1 dose coverage mea-
sured at 6 months increased by 0.7 pp to 95.9% (Table 2). Similarly,
between July 2017 and April 2019, while coverage for the com-
pleted primary course of pentavalent/hexavalent vaccine (3 doses,
measured at 12 months) decreased by 1.2 pp to 92%, 1 dose cover-
age measured at 6 months increased by 0.5 pp to 96.2% (Table 2).Table 1
Change in coverage percentage points among selected vaccinations, England.
England
Region
Change in DTaP/IPV/Hib
coverage at 2 years, 2012/13 to
2018/19 (%)
Change in MMR1 coverage
at 2 years, 2013/14 to
2018/19 (%)
North East 1.1 1.0
North West 2.9 2.4
Yorkshire
and the
Humber
2.0 1.8
East
Midlands
2.1 2.9
West
Midlands
2.0 2.9
East of
England
1.9 2.4
London 2.9 4.5
South East 1.5 0.4
South West 1.4 1.2
England
Total
2.1 2.3
Table 2
Vaccine coverage for first dose and completed courses for selected vaccines, England.
Hexavalent vaccine
Time period 1st dose coverage at 6 months
(%)*
Completed course at 12
(%)**
Jul-17 95.7 93.2
Oct-17 95.6 93.1
Jan-18 95.4 92.6
Apr-18 95.3
Jul-18 94.8 91.6
Oct-18 96 92.1
Jan-19 96.1 91.9
Apr-19 96.2 92
Change over time
period
+0.5 pp 1.2 pp
* ImmForm data.
** COVER data.3.3. Specificity
During the vaccine scares around MMR in the 1990 s/2000 s and
pertussis in the 1970 s, vaccine coverage for MMR (Fig. 2a) and per-
tussis (Fig. 2b) in England fell for those specific vaccines only, but
coverage for other vaccines remained relatively stable. While MMR
coverage lost 11 pp between 1997/98 and 2003/04, DTaP/IPV/Hib
coverage only lost 2 pp. Similarly, between 1971 and 1976, at
the height of the pertussis scare, pertussis coverage decreased by
47 pp while polio coverage decreased by 2 pp only.
In the recent period, the magnitude and direction of trends var-
ied from one vaccine to another. Fig. 3c highlights that coverage
decreased for vaccines that delivered in primary care, including
DTaP/IPV/Hib and MMR1 at 12 and 24 months respectively (1.6
and 1.1 pp respectively), together with shingles delivered to
elderly individuals (17.4 pp) and HPV delivered to teenage girls
in schools (1.7 pp). In the same time period, vaccine coverage
increased for the school-based MenACWY and Td/IPV programmes
(+2.1 and +2 pp, respectively), antenatal pertussis delivered to
pregnant women mainly in primary care (+15.4 pp) and primary
care-based seasonal flu programme for 2 year-old children
(+0.2 pp). These differences in magnitude and direction of trends
cannot be easily explained by a generic change in attitudes to vac-
cination, nor by a specific one. Trends were also not specific to par-
ticular age group. Among young children, coverage for some
vaccines declined (DTaP/IPV/Hib and MMR) while coverage for
others increased (influenza). Similarly, among teenagers, coverage
for HPV decreased slightly whereas MenACWY and Td/IPV cover-
age increased and, among adults, antenatal pertussis coverage
increased whereas shingles coverage decreased.3.4. Criteria 4 and 5: Biological gradient and temporality
Trends in vaccine confidence based on the PHE attitudinal sur-
vey and vaccine coverage during the same time period suggest that
the decline in vaccine coverage was preceded by an increase in vac-
cine confidence and a decrease in the proportion of parents encoun-
tering anti-vaccination materials (Fig. 3). Compared with 2005/06,
an additional 23% of parents declared automatically vaccinating
their 0–2 year-old child when a vaccine was due in 2018/19, yet
DTaP/IPV/Hib coverage at 2 years was exactly the same in both
years (Table 3). In 2018/19, the proportion of parents automatically
vaccinating their 0–2 year olds was at its highest in 14 years (91%),
and the proportion of parents encountering material that might
persuade them not to immunise was at its lowest in 14 years
(8%), and yet DTaP/IPV/Hib coverage at 2 years was it its lowest
(94%, Table 3).MenB vaccine
months 1st dose coverage at 6 months
(%)*
Completed course at 12 months
(%)*
95.2 92.7
95.9 93
95.8 92.5
95.9
95.7 91.9
95.8 92.3
95.8 92
95.9 92.2
+0.7 pp 0.5 pp
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Fig 2. Vaccine coverage for selected vaccines and selected time periods, England.
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Between 2017 and 2019, there were 187,182 UK-specific
tweets about vaccination posted. The sentiment index (calculated
as the mean of predicted labels) during this time period was con-
stantly above 0, meaning that the volume of tweets positive
towards vaccination was always larger than the volume of tweets
conveying a negative sentiment (Fig. 3). During the study period,as the volume of tweets increased, attitudes towards vaccination
became increasingly positive with the sentiment index increasing
from 0.3 in July 2017 to 0.6 in October 2019. These trends, which
are consistent with PHE’s attitudinal survey [18] and the findings
from the EC report on vaccine confidence [5], do not provide a
coherent story to support the hypothesis that the recent decline
in vaccine coverage is due to increasing anti-vaccination
sentiment.
Fig 3. Vaccine Sentiment index between July 2017 and October 2019 of UK-specific Twitter data.
Table 3
Vaccine coverage and vaccination behaviour among parents, England 2004–2019.
Year DTaP/Hib/
IPV
Vaccine
coverage
at 2 years
(%)
Proportion of
parents who
automatically
vaccinate their
child when due (%)
Proportion of
parents of 0–2 year
olds who saw
anything that might
persuade them not
to immunise (%)
2004/05 94 61 23
2005/06 94 68 20
2006/07 93 70 14
2007/08 94 73 17
2008/09 94 72 14
2009/10 95 75 17
2010/11 96
2011/12 96
2012/13 96
2013/14 96
2014/15 96 90 12
2015/16 95 84 8
2016/17 95 89 10
2017/18 95 87 9
2018/19 94 91 8
Change from
2012/13 to
2018/19
2pp +1pp 4pp
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In England, coverage for most vaccines remains high and cover-
age for childhood vaccines, while not optimal, remains above 90%.
Compared with other countries, England continues to achieve high
coverage for vaccines delivered at an older age. For example, in
2018, the Netherlands and Sweden achieved 45% and 81% cover-
age, respectively, for HPV among 14 year-old females [20,21], com-
pared with 83.8% in England (Fig. 2c). In 2016, the USA achieved
48.2% coverage for antenatal pertussis [22] compared with 72.3%
in England (Fig. 2c). In 2016, the UK achieved 70.5% coverage for
influenza in individuals aged 65 and over, higher than any other
country in the EU [5]. Nevertheless, the decline in vaccine coverage
in England is a concern, in particular in the context of a resurgence
of measles in Europe and beyond [23].
Because of reported increases in anti-vaccination activity that
have recently been highlighted in communication channels aimed
at the general public and the public health community, and
because of the temporal association with the small but steady
decrease in vaccine coverage across England, it is tempting to linkthe two and attribute this decline to the rise in anti-vaccination
sentiment. National-level evidence, however, as well as compar-
ison with other industrialised countries across Europe and world-
wide suggest that confidence in the vaccine programme in
England has increased in recent years. Our systematic analysis of
vaccine coverage data does not highlight a strong, consistent,
specific, temporal or dose-specific association between reporting
of anti-vaccination sentiment and vaccine coverage in England.
While none of these analyses in isolation constitute high-grade evi-
dence, when considered collectively, they make a compelling case.
This implies that anti-vaccination sentiment is unlikely to be a
major contributor to the small decline in coverage for some of
the vaccines in England.
Because of the nature of social media, it is difficult for public
health services to truly quantify the size and influence of online
anti-vaccination movements. Evidence suggests that anti-
vaccination messages are dwarfed in volume by pro-vaccination
ones, that the volume of anti-vaccination messages has actually
decreased since 2014 [24] and the anti-vaccination community is
ideologically isolated [24,25], leading to an ‘‘echo chamber effect”
whereby anti-vaccination information is only consumed within
anti-vaccination groups [26]. This effect may very well be further
amplified by increased content moderation on social media plat-
forms in recent years. It is likely, therefore, that the attention the
media give to anti-vaccination groups is disproportionately high
compared to the actual impact they have, thereby artificially mak-
ing the problem appear bigger than it is. This may be as a result of
‘‘false balance”, a well-recognised issue in journalism where an
equal platform is given to views that do not have an equal weight
of evidence supporting them, simply for the sake of appearing bal-
anced [27]. This phenomenon was well-documented during the UK
MMR scare and contributed to the false impression that parents
had about the vaccine [28,29].
This study does not suggest that increasing anti-vaccination
sentiment can be dismissed or ignored. In some countries, confi-
dence in vaccination has clearly decreased either overall or for
specific vaccines [5]. The association between anti-vaccination
movement and broader ‘‘anti-expert” populist movements [30],
illustrated by prominent anti-vaccination figures having direct
access to politicians [31] is a concern for global public health. It
is perhaps reassuring, therefore, that the impact of anti-
vaccination movements is often specific to a particular geography
or context, and our study suggests that, for the moment, England
is relatively spared. In this context, it is important to avoid raising
the profile of the anti-vaccination groups andmessages, as drawing
attention to myths, even to pre-emptively counteract them, has
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nate [32,33].
While we have demonstrated the limited impact of anti-
vaccination sentiment on vaccine coverage in England, the analy-
ses performed in this study do not explain why coverage has
declined. While it is tempting to focus on a single explanation for
changes in vaccine coverage, the reality is likely to be more
nuanced and changes in vaccine coverage are most likely to be
the result of multiple interconnected factors. Evidence suggests
that a large-scale re-organisation of public health services in
2012/13, when public health services were taken out of health ser-
vices and integrated into local government, severely disrupted the
national immunisation programme and led to confusion about
respective roles and responsibilities for stakeholders involved in
the delivery of the programme [34]. In addition, changing migra-
tion patterns, with a higher proportion of the population belonging
to groups who face barriers to immunization [35], may also con-
tribute to the decline in vaccine coverage. Changes in the provision
of invitation (call/recall) systems, one of the most effective inter-
ventions to improve vaccine coverage [36], may have also had an
impact. A 2018 survey of general practices in London highlighted
that 15% of practices had no call/recall system in place [37]. Pri-
mary care capacity to provide a sufficient number of appointments
for vaccination may also play a role: GPs with a higher number of
appointments per eligible patient achieve higher vaccination rates
[38], and GP list sizes have increased between 2015 and 2020 [39].
This is consistent with coverage in GP-delivered childhood vacci-
nes declining whereas coverage for most school delivered pro-
grammes increasing. The National Audit Office reviewed the
childhood vaccination programme in England in in 2019 and, con-
sistent with our findings, concluded that health system barriers
and data system accuracy, rather than anti-vaccination messages,
were the underlying reason for the decline in vaccine coverage
[40]. A coordinated approach with clear roles and responsibilities
between all agencies responsible for the commissioning, imple-
mentation, delivery, monitoring and governance of the immunisa-
tion programme, is essential to identify and address the causes of
declining vaccine coverage are identified and addressed. In July
2019 The Department of Health announced a national Vaccination
strategy [41] that will bring together Public Health England, NHS
England and other stakeholders to collectively address system
level barriers to reach 95% uptake for childhood vaccinations.5. Conclusion
The immunisation programme in England is facing some seri-
ous challenges. For now, the anti-vaccination movement isn’t the
main one, and giving too much public coverage to the anti-
vaccination views of a small minority can be harmful. It is essential
that we, the public health community, do not contribute to making
the problem appear bigger than it actually is. The best way to
ensure this is by continuing to monitor and understand parental
views and needs, and to ensure that health care professionals are
well equipped to address parental concerns. Alongside this, the
main focus should address the known system issues affecting the
delivery of our immunisation programme in order to make it easy
to get vaccinated and maximise protection against vaccine-
preventable diseases.Data Sharing
This study relies primarily on publicly available vaccine cover-
age data and the sources of data used are listed in Appendix 1,
together with the relevant URLs. One of the vaccine coverage data
sources (DTaP/IPV/Hib +/- HepB Dose 1measured at 6 months isnot publicly available) but can be provided on request. Data from
the attitudinal survey from 2016 onwards is being used for a
manuscript currently in preparation and will become available
through the publication of that manuscript. The raw Twitter data
is available from a Github data repository and the URL is available
in Appendix 1.
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